Goldman Sachs Starts United Therapeutics Corp. (UTHR) at Sell

December 5, 2022 3:54 AM EST Send to a Friend
(Updated - December 5, 2022 3:55 AM EST)

Goldman Sachs analyst Chris Shibutani initiates coverage on United Therapeutics Corp ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login